These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34517465)

  • 21. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.
    Krajden M; Ziermann R; Khan A; Mak A; Leung K; Hendricks D; Comanor L
    J Clin Microbiol; 2002 Aug; 40(8):2903-7. PubMed ID: 12149349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
    Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y
    J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Markers of hepatitis virus].
    Suzuki F
    Rinsho Byori; 2008 Nov; 56(11):1014-8. PubMed ID: 19086457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay.
    Grant PR; Sims CM; Krieg-Schneider F; Love EM; Eglin R; Tedder RS
    Vox Sang; 2002 May; 82(4):169-76. PubMed ID: 12047510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High selective spectroelectrochemical biosensor for HCV-RNA detection based on a specific peptide nucleic acid.
    El-Said WA; Choi JW
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jun; 217():288-293. PubMed ID: 30952095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.
    Zhang HQ; Li SB; Wang GH; Chen K; Song XG; Feng XY
    World J Gastroenterol; 2007 May; 13(19):2738-42. PubMed ID: 17569145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
    Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
    J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and monitoring of HCV infection using the cobas
    Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
    J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for near full-length amplification and sequencing for six hepatitis C virus genotypes.
    Bull RA; Eltahla AA; Rodrigo C; Koekkoek SM; Walker M; Pirozyan MR; Betz-Stablein B; Toepfer A; Laird M; Oh S; Heiner C; Maher L; Schinkel J; Lloyd AR; Luciani F
    BMC Genomics; 2016 Mar; 17():247. PubMed ID: 26988550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Using the mass spectrometry analysis for hepatitis C virus typing].
    Il'ina EN; Malakhova MV; Generozov EV; Govorun VM; Archakov AI; Pokrovskiĭ VI
    Biomed Khim; 2005; 51(1):41-7. PubMed ID: 15850217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology.
    Gentili G; Pisani G; Saldanha J; Cristiano K; Wirz M; Bisso GM; Mele C;
    Vox Sang; 2003 Aug; 85(2):114-6. PubMed ID: 12925164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
    Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
    Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
    J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.